'The sleeper has awakened': Top broker gives its verdict on the A2 Milk (ASX:A2M) share price

Is it time to buy A2 Milk shares?

| More on:
A man wakes up happy with a smile on his face and arms outstretched.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • A2 Milk's shares surged higher yesterday following the release of its half year results
  • One leading broker has been reviewing the result and liked what it saw
  • It believes the 'sleeper has awakened' and has reaffirmed its buy rating

The A2 Milk Company Ltd (ASX: A2M) share price was among the best performers on the ASX 200 on Monday.

Investors were bidding the infant formula company's shares higher following the release of its half year results.

What happened during the first half?

For the six months ended 31 December, A2 Milk reported a 2.5% decline in revenue over the prior corresponding period to NZ$661 million. Though, this figure is a bit misleading as it includes the Mataura Valley Milk (MVM) business, which was acquired in late FY 2021 and thus was not part of the prior period's numbers.

A better reflection on its performance comes from its Infant Nutrition and Liquid Milk businesses, which reported a 10.5% decline in revenue to NZ$471 million and a 0.2% lift in revenue to NZ$125 million, respectively.

And, as was widely expected, on the bottom line A2 Milk's net profit after tax more than halved to NZ$56 million.

So why did the A2 Milk share price storm higher?

Investors appeared to be more interested in what management was saying rather than its results.

It commented: "The Company's outlook for 2H22 revenue has improved. It is still expected to be significantly higher than 2H21, and with growth now expected on 1H22 and for FY22, ahead of initial expectations due mainly to growth in China label and English label IMF."

This appears to have sparked hopes that the worst could now be behind the former market darling.

Broker remains positive

In response to the result, the team at Bell Potter has retained its buy rating and $7.70 price target on the company's shares.

Based on the current A2 Milk share price of $5.81, this implies potential upside of 32% for investors over the next 12 months.

Having reviewed the result, Bell Potter believes "the sleeper has awakened."

It commented: "Our Buy rating remains unchanged. We saw plenty to like in this result: (1) growth in stage 1 market share in the MBS channel from 2.1% to 2.5% (indicative of new customer recruitment); (2) a beat in China direct channels sales in 1H22 and a closer alignment of sell-in and sell-out levels in 2Q22; (3) reinvestment of outperformance into marketing, to support FY23-24e revenue growth; and (4) progress on articulating a margin capture strategy at MVM."

Time will tell whether this is the right call on the A2 Milk share price.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Hand of a woman carrying a bag of money, representing the concept of saving money or earning dividends.
Broker Notes

Bell Potter names more of the best ASX 200 stocks to buy in April

Its analysts believe these shares 'offer attractive risk-adjusted returns over the long term.'

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A woman sits on sofa pondering a question.
Broker Notes

Battle of the online classifieds: Should I buy Car Group or Seek shares?

Brokers rate both shares highly.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

2 top quality ASX 200 shares to buy after the market selloff

Bell Potter speaks very highly about these shares. Let's see why they could be strong buys.

Read more »

A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer
Broker Notes

The ASX share market selloff has created a 'valuable window to buy quality stocks'

The broker thinks investors should be focusing on quality now.

Read more »

A young well-dressed couple at a luxury resort celebrate successful life choices.
Broker Notes

'This is a great time to get rich': 3 of the best ASX shares to buy

The US President has made a bold claim over the weekend.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

10 ASX shares to buy after the market selloff

Analysts think these shares could be strong buys after recent weakness. Let's see what they are recommending.

Read more »